$PMCB “The data presented at the meeting of the International Diabetes Consortium clearly show that PharmaCyte is making excellent progress in developing what we believe will become a new game-changing therapy for insulin-dependent diabetes - a debilitating and even life-threatening disease with an ever increasing incidence that affects so many around the world. The marriage of Cell-in-a-Box® with the unique Melligen cells to create a true “bio-artificial pancreas” that is both long-lived and effective will be key to treating this devastating disease.”